Sun Pharma unit recalls capsules from US

Sun Pharma unit recalls capsules from US

FPJ BureauUpdated: Saturday, June 01, 2019, 09:33 AM IST
article-image

Hyderabad: Caraco Pharmaceutical Laboratories , a unit of Sun Pharma, has initiated a recall of multiple lots of Cephalexin capsules from the US market.  According to a notification by the USFDA, the recall of the 3,40,553 units of 500 mg and 1,13,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to the regulator in June under ‘Class-II’ classification.  

“CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices,” the USFDA’s website said.  When contacted, a Sun Pharma spokesperson offered no comments.

RECENT STORIES

OnePlus Buds 4 With Up To 45 Hours Battery Life, Adaptive Mode Launched In India: Price And Features

OnePlus Buds 4 With Up To 45 Hours Battery Life, Adaptive Mode Launched In India: Price And Features

Electric Vehicle Sales In India Rise 28.60% To 1,80,238 Units In June, Driven By Massive Jump In...

Electric Vehicle Sales In India Rise 28.60% To 1,80,238 Units In June, Driven By Massive Jump In...

Hindustan Power Commences Work On 435 Megawatt Peak Solar Power Project At Lalitpur In Uttar Pradesh...

Hindustan Power Commences Work On 435 Megawatt Peak Solar Power Project At Lalitpur In Uttar Pradesh...

Amazon Charges Customers Marketplace Fee, Enabling Convenient Access To A Large Range Of Products...

Amazon Charges Customers Marketplace Fee, Enabling Convenient Access To A Large Range Of Products...

MCX Launches Electricity Futures, Strengthens Its Energy & Commodities Portfolio

MCX Launches Electricity Futures, Strengthens Its Energy & Commodities Portfolio